Clinical trials
Phase 1/2 Adenocarcinoma of Lung trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2011 | 3 |
| 2014 | 2 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Withdrawn | 7 |
| Terminated | 6 |
| Recruiting | 3 |
| Active, not recruiting | 2 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Memorial Sloan Kettering Cancer Center | 2 |
| National Cancer Institute (NCI) | 2 |
| Radiation Therapy Oncology Group | 2 |
| Wake Forest University Health Sciences | 2 |
| AIO-Studien-gGmbH | 1 |
| Agennix | 1 |
| Alaunos Therapeutics | 1 |
| Amgen | 1 |
| AstraZeneca | 1 |
| Barbara Ann Karmanos Cancer Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adenocarcinoma of Lung | 31 |
| Carcinoma, Non-Small-Cell Lung | 19 |
| Lung Neoplasms | 15 |
| Adenocarcinoma, Bronchiolo-Alveolar | 4 |
| Neoplasm Metastasis | 4 |
| Endometrial Neoplasms | 3 |
| Ovarian Neoplasms | 3 |
| Pancreatic Neoplasms | 3 |
| Adenocarcinoma | 2 |
| Cholangiocarcinoma | 2 |
Trials
Showing 76 to 31 of 31. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.